SEQUENCING For US Genomics, DNA Flows, and Money Does Too | GenomeWeb

US Genomics, catapulted to industry attention with Craig Venter’s endorsement and its buzzed-about video of unspooling single molecules of DNA, has embarked on raising a fourth round of private equity investment, hoping to secure enough money to last the company three years, according to CEO Eugene Chan.

“We want to raise enough money to take us to profitability and a public offering before three years are up, maybe as early as 18 months,” he says.

Get the full story with
GenomeWeb Premium

Only $95 for the
first 90 days*

A trial upgrade to GenomeWeb Premium gives you full site access, interest-based email alerts, access to archives, and more. Never miss another important industry story.

Try GenomeWeb Premium now.

Already a GenomeWeb Premium member? Login Now.
Or, See if your institution qualifies for premium access.

*Before your trial expires, we’ll put together a custom quote with your long-term premium options.

Not ready for premium?

Register for Free Content
You can still register for access to our free content.

The Wall Street Journal reports that National Institutes of Health Director Francis Collins' response to contamination concerns at the agency might have delayed care.

The final revision of the Common Rule doesn't include the proposed change requiring consent for leftover biospecimens.

The first Reproducibility Project: Cancer Biology papers show mixed results.

In Nature this week: mobile phone-based targeted DNA sequencing, and more.